This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Medicines for Malaria Venture (Mmv). Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Sanjay Babu Katiyar: Innovator in Antimalarial Compounds
Introduction
Sanjay Babu Katiyar is a notable inventor based in Salt Lake, Indiana. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antimalarial compounds. His work focuses on creating effective treatments for malaria, a disease that continues to pose a global health challenge.
Latest Patents
Sanjay holds a patent for "Antimalarial compounds with flexible side-chains." This invention relates to novel compounds that act as inhibitors of both wild type and mutant dihydrofolate reductase (DHFR). These compounds are particularly useful for the treatment of malaria. The antimalarial compounds developed by Sanjay exhibit low toxicity to hosts infected with the malarial parasite and demonstrate potency when administered in pharmaceutical compositions. He has 1 patent to his name.
Career Highlights
Sanjay Babu Katiyar is associated with Medicines for Malaria Venture (MMV), an organization dedicated to reducing the burden of malaria through innovative research and development. His work at MMV has been instrumental in advancing the understanding and treatment of malaria.
Collaborations
Sanjay has collaborated with esteemed colleagues in the field, including Yongyuth Yuthavong and Tirayut Vilaivan. These collaborations have further enriched his research and contributed to the development of effective antimalarial therapies.
Conclusion
Sanjay Babu Katiyar's innovative work in the field of antimalarial compounds highlights his commitment to addressing critical health issues. His contributions are paving the way for more effective treatments for malaria, ultimately benefiting global health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile